KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions

Nastaran Karimi, Seyed Javad Moghaddam

Research output: Contribution to journalReview articlepeer-review

6 Scopus citations

Fingerprint

Dive into the research topics of 'KRAS-Mutant Lung Cancer: Targeting Molecular and Immunologic Pathways, Therapeutic Advantages and Restrictions'. Together they form a unique fingerprint.

Medicine & Life Sciences

Chemistry